Bionova Capital logo

Bionova Capital

Europe, Lisboa, Portugal, Lisbon

Description

Bionova Capital is a healthcare-focused venture capital firm, investing in early-stage startups across Europe.

Investor Profile

Bionova Capital has made 7 investments, with 0 in the past 12 months and 14% as lead.

Stage Focus

  • Seed (71%)
  • Series A (14%)
  • Series Unknown (14%)

Country Focus

  • Portugal (57%)
  • United Kingdom (43%)

Industry Focus

  • Biotechnology
  • Health Care
  • Hospital
  • Medical Device
  • Biopharma
  • Medical
  • Oncology
  • Artificial Intelligence (Ai)
  • Information Services
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bionova Capital frequently co-invest with?

Seneca Partners
Europe, St. Helens, United Kingdom, Haydock
Co-Investments: 1
Eva Pharma
Africa, Al Jizah, Egypt, Gîza
Co-Investments: 1
Caixa Capital
Europe, Lisboa, Portugal, Lisbon
Co-Investments: 2
Portugal Ventures
Europe, Lisboa, Portugal, Porto
Co-Investments: 1
BB
Europe, Hessen, Germany, Zwingenberg
Co-Investments: 1
Mercia Fund Managers
Europe, Warwickshire, United Kingdom, Henley In Arden
Co-Investments: 2
ACF Investors
Europe, Sheffield, United Kingdom, Sheffield
Co-Investments: 1
Development Bank of Wales
Europe, Cardiff, United Kingdom, Cardiff
Co-Investments: 1
KV
Europe, Southern Finland, Finland, Helsinki
Co-Investments: 1
Wealth Club
Europe, Bristol, City of, United Kingdom, Bristol
Co-Investments: 1

Which angels does Bionova Capital often collaborate with?

FF
Europe, Auvergne, France, Mayet-de-montagne
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Bionova Capital?

Delox

Cascais, Lisboa, Portugal

Delox is designing and developing a new generation of bio-decontamination devices.

BiotechnologyHealth CareHospital
SeedMay 18, 2022
Amount Raised: $785,503
SolasCure

Cambridge, Cambridgeshire, United Kingdom

Transforming chronic wound care with breakthrough enzymatic technology

BiopharmaBiotechnologyHealth CareMedical
Series AAug 9, 2021
Amount Raised: $20,769,755
Adapttech

Birmingham, Birmingham, United Kingdom

Adapttech develops ingenious biomedical technologies to help people with physical limitations improve their quality of life

BiotechnologyMedical Device
Series UnknownMar 23, 2021
Amount Raised: $2,746,155
CellmAbs

Lisbon, Lisboa, Portugal

CellmAbs provides research and development services on novel anti-cancer treatments.

BiotechnologyOncology
SeedNov 13, 2019
Amount Raised: $1,600,000
Delox

Cascais, Lisboa, Portugal

Delox is designing and developing a new generation of bio-decontamination devices.

BiotechnologyHealth CareHospital
SeedJul 1, 2018
Amount Raised: $350,385
Adapttech

Birmingham, Birmingham, United Kingdom

Adapttech develops ingenious biomedical technologies to help people with physical limitations improve their quality of life

BiotechnologyMedical Device
SeedMay 16, 2016
Amount Raised: $1,871,664
Anybrain

Braga, Braga, Portugal

Anybrain is a artificial intelligence and data processing firm.

Artificial Intelligence (AI)Information ServicesInformation TechnologyMachine LearningSoftware
SeedOct 30, 2015